LYNDSAY FUNK-PURCELL: Open Payments
NPI 1124784657 · SHOW LOW, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$178 in 10 payments from 5 companies in 2025. Trend: 2023 $623 · 2024 $385 · 2025 $178
Food & beverage: $178
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 4 | $67 |
| Novo Nordisk Inc | 3 | $55 |
| ABBVIE INC. | 1 | $26 |
| GlaxoSmithKline, LLC. | 1 | $17 |
| Aimmune Therapeutics, Inc. | 1 | $14 |
Products named: TRUMENBA, ELIQUIS, DALVANCE, Wegovy, Ozempic, SHINGRIX, Rybelsus, ZENPEP.
Industry payments across AZ — which companies pay providers there.
